Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease—an observational study

Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease—an observational study

ObjectiveThe study aimed to observe the quantity of platelet aggregation in the hepatic tissue of patients with metabolic-associated fatty liver disease (MAFLD) and its relationship with hepatic inflammation, fibrosis, and fatty degeneration.MethodsClinical data of 55 patients with MAFLD and 25 pati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rongshan Fan, Yandong Li, Zeng Du
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Medicine
Subjects:	metabolic-associated fatty liver disease hepatic tissue platelet aggregation hepatic inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1503090/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters
by: Katherine J. P. Schwenger, et al.
Published: (2025-01-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Positive association between proinsulin and fatty liver index in people with type 2 diabetes
by: Akinobu Nakamura, et al.
Published: (2024-02-01)

Ultrasound-guided percutaneous microwave ablation for metabolic-associated fatty liver disease-related hepatocellular carcinoma (HCC) versus hepatitis virus B-related HCC: a propensity score matching study
by: Yannan Qiao, et al.
Published: (2024-12-01)

Cellular and immune landscape of chronic liver diseases: insights from immunophenotyping
by: Shaghayegh Soleimani, et al.
Published: (2025-01-01)

Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
by: Jaejun Lee, et al.
Published: (2025-01-01)

Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
by: K. I. Yesmembetov, et al.
Published: (2013-07-01)

Factors associated with seropositivity of Hepatitis B & C: A case control study at Azad Jammu and Kashmir
by: Muhammad Abdul Quddus, et al.
Published: (2023-04-01)

Platelet‐derived apoptotic vesicles ameliorate nonalcoholic fatty liver disease by regulating lipid metabolism via apolipoprotein A‐II
by: Yuhe Jiang, et al.
Published: (2025-01-01)

Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis
by: Abdullah A. Awadh, et al.
Published: (2024-12-01)

Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
by: Haiyong Zeng, et al.
Published: (2025-02-01)

Miliary Tuberculosis Initially Presenting as an Isolated Hepatic Abscess
by: Chang Won Ha, et al.
Published: (2025-01-01)

Long-term Outcomes (10 years) of Hepatic Transplantation in a Patient with Hepatic Adenomatosis: A Case Report
by: Abdullah Almunifi
Published: (2024-12-01)

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01)

A novel human specific lncRNA MEK6-AS1 regulates adipogenesis and fatty acid biosynthesis by stabilizing MEK6 mRNA
by: Di Li, et al.
Published: (2025-01-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Targeted Plasma Bile Acid Metabolomic Analysis in Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Hepatitis
by: Yuta Hirata, et al.
Published: (2024-12-01)

Sodium-glucose cotransporter-2 inhibitors improve liver enzymes in patients with co-existing non-alcoholic fatty liver disease: a systematic review and metanalysis
by: Waseem Amjad, et al.
Published: (2022-01-01)

Using platelet concentrates to treat maxillofacial tissue lesions
by: Ruijia Liu, et al.
Published: (2025-01-01)

POTENTIAL OF ALOE VERA GEL AS AN ALTERNATIVE INDUCTOR IN PLATELET AGGREGATION TEST
by: Gela Setya Ayu Putri, et al.
Published: (2023-06-01)

Age-Dependent Effects of Butyl Benzyl Phthalate Exposure on Lipid Metabolism and Hepatic Fibrosis in Mice
by: Min-Seo Park, et al.
Published: (2025-01-01)

Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005–2016
by: Yidian Fu, et al.
Published: (2025-01-01)

Platelet–Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease
by: Yuan Zhang, et al.
Published: (2025-02-01)

Transfusion-transmitted hepatitis E
by: LI Baixun, et al.
Published: (2025-01-01)

Association between overt hepatic encephalopathy and liver pathology after transjugular intrahepatic portosystemic shunt creation in cirrhotic patients
by: Chaoyang Wang, et al.
Published: (2025-01-01)

Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis
by: Shan Wang, et al.
Published: (2025-01-01)

Evaluating platelet concentrates by platelet indices, thromboelastography, and flow cytometry
by: Tapasyapreeti Mukhopadhyay, et al.
Published: (2024-12-01)

Treatment of chronic hepatitis B: options, monitoring, special cases and adverse effects
by: Mateusz Litwin Litwin, et al.
Published: (2025-01-01)

Oxidative stress in viral hepatitis
by: Huseyin Erdal, et al.
Published: (2024-04-01)

Advancing Platelet Research Through Live-Cell Imaging: Challenges, Techniques, and Insights
by: Yuping Yolanda Tan, et al.
Published: (2025-01-01)

Time-restricted feeding improves metabolic syndrome by activating thermogenesis in brown adipose tissue and reducing inflammatory markers
by: Yueling Gong, et al.
Published: (2025-01-01)

Winery By-Products In Vitro and In Vivo Effects on Atherothrombotic Markers: Focus on Platelet-Activating Factor
by: Maria Choleva, et al.
Published: (2025-01-01)

Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01)

Comparison of the performances between ChatGPT and Gemini in answering questions on viral hepatitis
by: Meryem Sahin Ozdemir, et al.
Published: (2025-01-01)

Genome-Wide Association Study of Hepatitis in Korean Populations
by: Youngbok Hong, et al.
Published: (2014-12-01)

Noninvasive diagnosis model for predicting significant liver inflammation in patients with chronic hepatitis B in the immune-tolerant phase
by: Shanshan Chen, et al.
Published: (2025-01-01)

Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01)

Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections
by: Jennifer Molle, et al.
Published: (2024-12-01)

Benefits of Liver Volume and Serum Zinc Level Assessment for the Screening of Covert Hepatic Encephalopathy in Patients with Child–Pugh Class A Cirrhosis
by: Masanori Fukushima, et al.
Published: (2024-12-01)